Medical therapy of acute kidney injury (Q37088297)

18 August 2017

1 reference

title

Medical therapy of acute kidney injury (English)

1 reference

18 August 2017

M Joannidis

1

1 reference

18 August 2017

publication date

1 January 2007

1 reference

18 August 2017

1 reference

18 August 2017

volume

62 Suppl 2

1 reference

18 August 2017

page(s)

353-356

1 reference

Epidemiology and natural history of acute renal failure in the ICU.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

The effects of norepinephrine on hemodynamics and renal function in severe septic shock states

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

'Low-dose' dopamine worsens renal perfusion in patients with acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Fenoldopam in the prevention of contrast media-induced acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

N-acetylcysteine ameliorates renal microcirculation: studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Subcutaneous administration of the cardiac hormone BNP in symptomatic human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Effects of furosemide on medullary oxygenation in younger and older subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Meta-analysis of frusemide to prevent or treat acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Nitric oxide and superoxide in the renal medulla: a delicate balancing act.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

The involvement of oxidative stress in the progression of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

N-acetylcysteine for the prevention of kidney injury in abdominal aortic surgery: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Lack of protection of N-acetylcysteine (NAC) in acute renal failure related to elective aortic aneurysm repair-a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

Erythropoietin protects against ischaemic acute renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2007.079

21 January 2018

Identifiers

DOI

10.1179/ACB.2007.079

1 reference

18 August 2017

1 reference